Latest news with #CoconutCreek
Associated Press
09-07-2025
- Health
- Associated Press
South Florida Vascular Associates Introduces Genicular Artery Embolization (GAE) for Knee Osteoarthritis Relief
Summary: South Florida Vascular Associates introduces Genicular Artery Embolization (GAE) as a treatment option for knee osteoarthritis, offering a faster recovery, reduced pain, and an alternative to surgery. Coconut Creek, Florida--(Newsfile Corp. - July 9, 2025) - South Florida Vascular Associates recently announced the launch of Genicular Artery Embolization (GAE), a minimally invasive procedure designed to alleviate pain associated with knee osteoarthritis (OA). This innovative treatment provides patients with alternative means of managing chronic knee pain before considering invasive options, such as surgery. The launch of GAE aligns with South Florida Vascular Associates' commitment to offering advanced, image-guided procedures that address the growing need for non-invasive treatments. GAE allows for a quicker recovery time, with most procedures taking only 60 to 90 minutes, enabling patients to return home the same day. This aligns with the growing demand for outpatient treatments, which offer patients a convenient and cost-effective option for relief without the downtime typically associated with surgery. Osteoarthritis (OA) of the knee is a widespread condition that has been on the rise for decades. While it is often associated with an aging population, changes in lifestyle and activity factors have also led to younger adults developing OA. By introducing GAE, South Florida Vascular Associates aims to help more people and ensure they lead more fulfilling lives. As part of its approach to offering this new procedure, South Florida Vascular Associates has ensured that all staff members are fully trained in the latest techniques for GAE, enabling a seamless process for patients from initial consultation to post-procedure recovery. The clinic has also integrated the procedure into its existing workflow to ensure consistent, high-quality care across all stages of treatment. South Florida Vascular Associates has reiterated its commitment to continually improving its services by evaluating new image-guided techniques. In addition to staying current with medical advancements, the practice is committed to integrating techniques that align with its goals of safety, outpatient care, and oversight. The practice believes that this will help patients avoid invasive procedures and, more importantly, unnecessary hospital visits. Additionally, South Florida Vascular Associates, through its founder, Dr. William Julien, emphasizes the importance of ongoing procedural development, particularly in the field of interventional medicine. The technology is continually improving, and the vascular interventional physician believes this is good news for patients. While this involves adding services for business and is often part of their internal growth, the clinic points out that the primary goal should be improving patient care. As knee osteoarthritis continues to affect millions of people, the introduction of GAE by South Florida Vascular Associates represents a significant step forward in providing patients with a more accessible and less invasive treatment option. With GAE, patients now have a viable alternative to traditional surgery, offering them hope for a more comfortable, pain-free future. About South Florida Vascular Associates: South Florida Vascular Associates has been serving patients in need of vascular care for more than 20 years. The clinic offers minimally invasive treatments, including uterine, prostate, and varicocele embolization, and is committed to patient safety, leveraging technology to provide advanced and efficient treatments. Media Contact: [ This image cannot be displayed. Please visit the source: ] To view an enhanced version of this graphic, please visit: Company Name: South Florida Vascular Associates Contact Person: Roco Julien Phone: (954) 725-4141 Address: 5300 W Hillsboro Blvd, Suite 107 City: Coconut Creek State: Florida Postal Code: Country: United States Website: To view the source version of this press release, please visit
Globe and Mail
18-06-2025
- Business
- Globe and Mail
Willis Lease Finance Corporation Announces Closing of $596.0 Million in Fixed Rate Notes
COCONUT CREEK, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) ('WLFC' or the 'Company'), the leading lessor of commercial aircraft engines and global provider of aviation services, announced today that its wholly-owned subsidiary, Willis Engine Structured Trust VIII ('WEST'), has completed the previously announced offering of $524,000,000 in aggregate principal amount of Series A Fixed Rate Notes (the 'Series A Notes') and $72,000,000 in aggregate principal amount of Series B Fixed Rate Notes (the 'Series B Notes' and, together with the Series A Notes, the 'Notes'). The Notes are secured by, among other things, WEST's direct and indirect interests in a portfolio of 62 aircraft engines and two airframes, which WEST will acquire from WLFC or its other subsidiaries, pursuant to an asset purchase agreement. The final subscription was 3.60x (gross) and 5.10x (avail) on the Series A Notes and 7.15x (gross) and 13.00x (avail) on the Series B Notes. The Series A Notes and Series B Notes have a fixed coupon of 5.582% and 6.070%, respectively, an expected maturity of approximately six years, an expected weighted average life (based on certain modeling assumptions) of 5.1 years and a final maturity of 25 years. The Series A Notes and Series B Notes were issued at a price of 99.99721% and 99.99711% of par, respectively. The Notes offered by WEST have not been and will not be registered under the Securities Act of 1933, as amended (the 'Securities Act'), or any other securities laws of any jurisdiction, and may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S under the Securities Act) absent registration or an applicable exemption from registration requirements. The Notes were offered only to persons reasonably believed to be 'qualified institutional buyers' as defined in, and in reliance on, Rule 144A under the Securities Act and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of, the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the Securities Act or the securities laws of any such jurisdiction. Willis Lease Finance Corporation Willis Lease Finance Corporation ('WLFC') leases large and regional spare commercial aircraft engines, auxiliary power units and aircraft to airlines, aircraft engine manufacturers and maintenance, repair, and overhaul providers worldwide. These leasing activities are integrated with engine and aircraft trading, engine lease pools and asset management services through Willis Asset Management Limited, as well as various end-of-life solutions for engines and aviation materials provided through Willis Aeronautical Services, Inc. Through Willis Engine Repair Center®, Jet Centre by Willis, and Willis Aviation Services Limited, the Company's service offerings include Part 145 engine maintenance, aircraft line and base maintenance, aircraft disassembly, parking and storage, airport FBO and ground and cargo handling services. Willis Sustainable Fuels intends to develop, build and operate projects to help decarbonize aviation. Except for historical information, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties. Do not unduly rely on forward-looking statements, which give only expectations about the future and are not guarantees. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which the forward-looking statement is based, except as required by law. Our actual results may differ materially from the results discussed in forward-looking statements. Factors that might cause such a difference include, but are not limited to: the effects on the airline industry and the global economy of events such as war, terrorist activity and the COVID-19 pandemic; changes in oil prices, rising inflation and other disruptions to world markets; trends in the airline industry and our ability to capitalize on those trends, including growth rates of markets and other economic factors; risks associated with owning and leasing jet engines and aircraft; our ability to successfully negotiate equipment purchases, sales and leases, to collect outstanding amounts due and to control costs and expenses; changes in interest rates and availability of capital, both to us and our customers; our ability to continue to meet changing customer demands; regulatory changes affecting airline operations, aircraft maintenance, accounting standards and taxes; the market value of engines and other assets in our portfolio; and risks detailed in the Company's Annual Report on Form 10-K and other continuing and current reports filed with the Securities and Exchange Commission. It is advisable, however, to consult any further disclosures the Company makes on related subjects in such filings. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.
